FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Pantoprazole Sodium Delayed-Release Tablets Recall

Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle,…

Aurobindo Pharma USA Inc · Plainsboro, NJ

Risk level
Class II
Reported by FDA
Sep 21, 2016
Recall ID
D-1499-2016
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Pantoprazole Sodium Delayed-Release Tablets starting Aug 3, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1499-2016 on Sep 21, 2016. Reason: Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.

Product description

Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90

Lot numbers, UPCs & expiration codes

PSSB16011-A, Exp 01/18

Where it was sold

CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1499-2016
Classification
Class II
Status
Terminated
Recall initiated
Aug 3, 2016
FDA report date
Sep 21, 2016
Quantity
23016 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc

Original FDA data

Every field from FDA enforcement report D-1499-2016, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
74949
Address
666 Plainsboro Rd Ste 210
Code information
PSSB16011-A, Exp 01/18
Postal code
08536-3004
Report date
Sep 21, 2016
Product type
Drugs
Recall number
D-1499-2016
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc
Product quantity
23016 bottles
Termination date
Jun 8, 2018
Reason for recall
Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90
Distribution pattern
CA
Recall initiation date
Aug 3, 2016
Initial firm notification
Letter
Center classification date
Sep 14, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1499-2016, published Sep 21, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls